Trials / Conditions / Recurrent Atypical Teratoid/Rhabdoid Tumor
Recurrent Atypical Teratoid/Rhabdoid Tumor
4 registered clinical trials studyying Recurrent Atypical Teratoid/Rhabdoid Tumor — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT) NCT07447076 | Sabine Mueller, MD, PhD | Phase 2 |
| Active Not Recruiting | Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors NCT05286801 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Withdrawn | Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer NCT04521946 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors NCT03387020 | Pediatric Brain Tumor Consortium | Phase 1 |